Molecular analysis of vesicular amine transporter function and targeting to secretory organelles

FASEB Journal

Volumn 14, Issue 15, 2000, Pages 2450-2458

  Erickson, J D ^a   Varoqui, H ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Acetylcholine; Biogenic amines; CAD; Large dense core vesicle; PC12; Quantal release; Small synaptic vesicle; Synaptic like microvesicle; Trafficking

Indexed keywords

ADRENALIN; DOPAMINE; HISTAMINE; MEMBRANE PROTEIN; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG; VESICULAR AMINE TRANSPORTER;

BINDING AFFINITY; CELL ORGANELLE; CELL VACUOLE; EXOCYTOSIS; HUMAN; NERVE CELL; NEUROSECRETION; NEUROSECRETORY CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW;

EID: 0033673394     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0206rev     Document Type: Review

References (87)

1. The role of vesicular transport proteins in synaptic transmission and neural degeneration
2. Vesicular neurotransmitter transporters: Potential sites for the regulation of synaptic function
3. The cholinergic gene locus
4. Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter
5. Reserpine binding to a vesicular amine transporter expressed in chinese hamster ovary fibroblasts
6. Radioligands of the vesicular monoamine transporter and their use as markers of the monoamine storage vesicles
7. In favour of the vesicular hypothesis: Neurochemical evidence that vasamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction
8. Acetylcholine transport, storage, and release
9. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors
10. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter
11. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechansm of action
12. The vesicular monoamine transporter-2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei
13. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites for somatodendritic storage and release of dopamine
14. Vesicular monoamine transporter-2: Immunogold localization in striatal axons and terminals
15. Biochemistry of somatodendritic dopamine release in substantia nigra: An in vivo comparison with striatal dopamine release
16. Neurosecretory vesicles can be hybrids of synaptic vesicles and secretory granules
17. Exocytosis from large and small dense cored vesicles in noradrenergic nerve terminals
18. Sorting and storage during secretory granule biogenesis: Looking backward and looking forward
19. Newly synthesized synaptophysin is transported to the synaptic-like microvesicles via constitutive secretory vesicles and the plasma membrane
20. Membrane composition of adrenergic large and small dense cored vesicles and of synaptic vesicles: Consequences for their biogenesis
21. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerve
22. Biogenesis of synaptic vesicle-like structures in a pheochromocytoma cell line PC-12
23. Sorting during transport to the surface of PC12 cells: Divergence of synaptic vesicle and secretory granule proteins
24. Colocalization of synaptophysin with transferrin receptors: Implications for synaptic vesicle biogenesis
25. The synaptic vesicle cycle: A single vesicle budding step involving clathrin and dynamin
26. Synaptic-like microvesicles of neuroendocrine cells originate from a novel compartment that is continuous with the plasma membrane and devoid of transferrin receptor
27. Neuroendocrine synaptic vesicles are formed in vitro by both clathrin-dependent and clathrin-independent pathways
28. Active transport of acetylcholine by the human vesicular acetylcholine transporter
29. Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging
30. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action
31. Bioenergetics of secretory vesicles
32. Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter
33. +-linked dopamine transport in chromaffin granule ghosts
34. Kinetic parameters for the vesicular acetylcholine transporter: Two protons are exchanged for one acetylcholine
35. Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat
36. Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition
37. Identification of residues involved in substrate recognition by a vesicular monoamine transporter
38. Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate
39. Mutational analysis of aspartate residues in the transmembrane regions and cytoplasmic loops of rat vesicular acetylcholine transporter
40. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles
41. Functional identification and molecular cloning of a human brain vesicle monoamine transporter
42. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2
43. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2
44. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine
45. A chimeric vesicular monoamine transporter dissociates sensitivity to tetrabenazine and unsubstituted aromatic amines
46. Analysis of neurotransmitter transport into secretory vesicles
47. Functional identification of vesicular monoamine and acetycholine transporters
48. Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells
49. Selective storage of acetylcholine, but not catecholamines, in neuroendocrine synaptic-like microvesicles of early endosomal origin
50. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles
51. The cytoplasmic tail of VAChT contains a synaptic vesicle targeting signal
52. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells
53. The vesicular monoamine transporter VMAT2 is targeted to large dense-core vesicles, and the vesicular acetylcholine transporter VAChT to small synaptic vesicles, in PC12 cells
54. Expression of the putative vesicular acetytcholine transporter in rat brain and localization in cholinergic synaptic vesicles
55. Fast axonal transport of the vesicular acetylcholine transporter (VAChT) in cholinergic neurons in the rat sciatic nerve
56. A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles
57. Selective depletion of the acetylcholine and vasoactive intestinal polypeptide of the guinea-pig myenteric plexus by differential mobilization of distinct transmitter pools
58. Retrieved constituents of large dense-cored vesicles and synaptic vesicles intermix in stimulation-induced early endosomes of noradrenergic neurons
59. Secretagogue-triggered transfer of membrane proteins from neuroendocrine secretory granules to synaptic-like microvesicles
60. A targeting signal in VAMP regulating transport to synaptic vesicles
61. Characterization of a CNS cell line. CAD, in which morphological differentiation is initiated by serum deprivation
62. Stimulation of vgf gene expression by NGF is mediated through multiple signal transduction pathways involving protein phosphorylation
63. A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters
64. Signal-dependent membrane protein trafficking in the endocytic pathway
65. Association of the AP-3 adaptor complex with clathrin
66. A function for the AP3 coat complex in synaptic vesicle formation from endosomes
67. Intracellular studies of dopamine neurons in vitro: Pacemakers modulated by dopamine
68. 3H] acetylcholine in the presence of vesamicol
69. Phosphorylation of the rat vesicular acetylcholine transporter
70. L-3,4-Dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro
71. Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum
72. Effects of choline administration on in vivo release and biosynthesis of acetylcholine in the rat striatum as studied by in vivo brain microdialysis
73. Choline acetyltransferase-deficient mutants of the nematode Caenorhabditis elegans
74. Choline acetyltransferase and acetylcholine levels in Drosophila melanogaster: A study using two temperature-sensitive mutants
75. Using Caenorhabditis degans to study vesicular transport
76. Isolation and characterization of mutants for the vesicular acetylcholine transporter gene in Drosophila melonagaster
77. Cholinergic synaptic vesicle heterogeneity: Evidence for regulation of acetylcholine transport
78. The heterogeneity of vesicular acetylcholine storage in cholinergic nerve terminals
79. Variation in GABA mini amplitude is the consequence of variation in transmitter concentration
80. Variability of neurotransmitter concentration and nonsaturation of postsynaptic AMPA receptors at synapses in hippocampal cultures and slices
81. The heterotrimeric G protein Go2 regulates catecholamine uptake by secretory vesicles
82. 2
83. Control of the binding of a vesamicol analog to the vesicular acetylcholine transporter
84. Protein kinase C and presynaptic moduilation of acetylcholine release in rabbit hippocampus
85. Down-regulation of quantal size at frog neuromuscular junctions: Possible roles for elevated intracellular calcium and for protein kinase C
86. Effects of activators and inhibitors of protein kinase A on increases in quantal size at the frog neuromuscular junction
87. Phosphorylation of a vesicular monoamine transporter by casein kinase II